The Yozma Group is a venture capital firm specializing in investments in all stages of development of a company.
Business Model:
Revenue: $6.7M
Employees: 2-10
Address: 40 Einstein St.
City: Tel Aviv
State: tel aviv district
Zip: 69 102
Country: IL
Yozma has earned worldwide recognition as the creator of the Israeli venture capital industry. Yozma makes equity investments in technology companies engaged in fields where Israel has demonstrated world leadership. The Group targets high-growth companies in the sectors of Communications, Information Technologies, and Life Sciences. Yozma effectively created the Israeli venture capital market in 1993 through the formation of its first venture fund, Yozma I. Originating from a government program aimed at prompting venture investments in Israel, Yozma I has transformed the domestic landscape of private equity investments. Over a period of three years, the Group established ten drop-down funds, each capitalized with more than $20 million. In parallel Yozma started making direct investments in start-up companies. This marked the beginning of a professionally managed venture capital market in Israel. Today, Yozma&s;s drop-down funds constitute the backbone of the Israeli venture market.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2022 | Meat.The End | Seed Round | 4M |
6/2021 | OP.GG | Series B | 20M |
1/2005 | NextNine | Venture Round | 0 |
9/2001 | Predix Pharmaceuticals | Venture Round | 7.8M |
11/2000 | Predix Pharmaceuticals | Series A | 3M |
1/2006 | Kailight Photonics | Series B | 4.5M |
1/2005 | Predix Pharmaceuticals | Series C | 0 |
7/1999 | Telegate Ltd. | Venture Round | 0 |
12/2005 | CogniTens | Series E | 0 |
1/1998 | NextNine | Seed Round | 4.5M |
5/2000 | Cardonet | Venture Round | 9M |
6/2002 | CanFite BioPharma | Venture Round | 12M |
5/2001 | Hywire | Venture Round | 5M |
1/2021 | Todos Medical | Convertible Note | 3.4M |
1/2001 | NextNine | Series B | 20M |
9/2006 | NextNine | Series C | 0 |
11/2021 | Illumigyn | Venture Round | 0 |
2/2000 | HarmonyCom | Series B | 7M |
9/2000 | Globecom Interactive | Series B | 2.5M |
5/2021 | UltraSight | Series B | 13M |
3/2019 | UltraSight | Series A | 2M |
5/2003 | CogniTens | Series D | 7.3M |
12/2022 | Meat.The End | Seed Round | 3.1M |
7/2020 | Nanox Imaging | Series B | 0 |
11/2021 | Illumigyn | Venture Round | 0 |
6/2021 | OP.GG | Series B | 0 |
5/2021 | UltraSight | Series B | 0 |
1/2021 | Todos Medical | Convertible Note | 0 |
7/2020 | Nanox Imaging | Series B | 0 |
3/2019 | UltraSight | Series A | 0 |
9/2006 | NextNine | Series C | 0 |
1/2006 | Kailight Photonics | Series B | 0 |
12/2005 | CogniTens | Series E | 0 |
1/2005 | Predix Pharmaceuticals | Series C | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2011 | Venture Round | 1 | $411.9k |
Cybele Holdings Cybele Holdings |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|